Alumis Inc. Common Stock vs. Eli Lilly & Co.
Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ALMS | LLY | |
|---|---|---|
| Market Cap | $1.23 billion | $1.03 trillion |
| Revenue (TTM) | $7.40 million | $79.67 billion |
| Net Income (TTM) | $-438,957,000 | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| ALMS | LLY | |
|---|---|---|
| P/E Ratio | — | 38.94 |
| Price / Book | 2.71 | 30.52 |
| Price / Sales | 165.69 | 12.98 |
ALMS and LLY split the valuation factors evenly.
Profitability
| ALMS | LLY | |
|---|---|---|
| Net Margin | -5933.45% | 33.53% |
| Return on Equity | -97.08% | 78.84% |
LLY leads on 2 of 2 profitability factors.
Dividend
| ALMS | LLY | |
|---|---|---|
| Dividend Yield | — | 0.60% |
| Payout Ratio | — | 23.23 |
ALMS and LLY split the dividend factors evenly.
Risk & Sentiment
| ALMS | LLY | |
|---|---|---|
| Short Interest | 0.47% | 1.29% |
ALMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALMS overview, ALMS financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.